Edition:
United States

Avinger Inc (AVGR.OQ)

AVGR.OQ on NASDAQ Stock Exchange Global Market

0.23USD
15 Dec 2017
Change (% chg)

$-0.00 (-0.26%)
Prev Close
$0.23
Open
$0.24
Day's High
$0.25
Day's Low
$0.22
Volume
253,605
Avg. Vol
337,829
52-wk High
$4.55
52-wk Low
$0.21

Chart for

About

Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease (PAD). The Company focuses on introducing products based on its lumivascular platform, which is an intravascul... (more)

Overall

Beta: --
Market Cap(Mil.): $7.28
Shares Outstanding(Mil.): 31.54
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 27.83 16.04
EPS (TTM): -- -- --
ROI: -- 10.00 34.69
ROE: -- 15.21 15.46

BRIEF-Avinger Secures Waiver And Consent To CRG Loan Agreement

* AVINGER SECURES WAIVER AND CONSENT TO CRG LOAN AGREEMENT Source text for Eikon: Further company coverage:

Dec 14 2017

BRIEF-Avinger Says Executive Chairman John Simpson Will Be Leaving Company

* AVINGER INC - JOHN B. SIMPSON, FOUNDER AND EXECUTIVE CHAIRMAN OF AVINGER, WILL BE LEAVING COMPANY

Dec 11 2017

BRIEF-Avinger Q3 loss per share $0.43

* Avinger Inc - ‍cash and cash equivalents totaled $10.2 million as of Sept 30, 2017, compared to $14.0 million as of June 30, 2017​ Source text for Eikon: Further company coverage:

Nov 09 2017

BRIEF-Avinger enters common stock purchase agreement for up to $15.0 mln with Lincoln Park Capital

* Avinger enters into common stock purchase agreement for up to $15.0 million with Lincoln Park Capital Source text for Eikon: Further company coverage:

Nov 06 2017

BRIEF-Avinger receives CE marking approval for in-stent restenosis treatment

* Avinger receives CE marking approval for in-stent restenosis treatment indication with pantheris image-guided atherectomy

Sep 26 2017

BRIEF-Avinger Q2 loss per share $0.54

* Q2 revenue fell 47 percent to $2.5 million Source text for Eikon: Further company coverage:

Aug 08 2017

Earnings vs. Estimates